Data / Form D filings / CB Pharma Acquisition Corp.
CB Pharma Acquisition Corp.: Form D filing
CB Pharma Acquisition Corp., a health care company in Burlington, MA, filed a Form D with the SEC in 2014. The latest, on December 11, 2014, reports $2.9 million sold of a $2.9 million offering to 2 investors.
Find out what CB Pharma Acquisition Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 24 NEW ENGLAND EXECUTIVE PARK, SUITE 105, Burlington, MA, 01803
- Phone
- (781) 652-4500
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Cayman Islands
- Year incorporated
- 2014
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1619551
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 11, 2014 | New notice | $2,850,000 | $2,850,000 | $0 | 2 | Nov 26, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Adam J. Chill | Director | |
| Neil A. Herskowitz | Director | |
| George C. Avgerinos | Executive Officer | |
| Michael S. Weiss | Director | |
| Arthur A. Kornbluth | Director | |
| n/a A. Coronado Biosciences, Inc. | Promoter | |
| Lindsay A. Rosenwald | Executive Officer, Director, Promoter |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
- REVBIO, INC. $15 million · Oct 2, 2026
- Fresenius Medical Care Will Clayton, LLC $3.8 million · Sep 21, 2026
- DynamiCare Health, Inc. $720,000 · Sep 10, 2026
- OnPoint Surgical, Inc. $18 million · Sep 1, 2026
Every Form D from the week of Dec 8, 2014 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what CB Pharma Acquisition Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.